Intermittent Fasting: Clinical Trials

7 trials for Intermittent Fasting, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 not yet recruiting, 1 completed, 1 unknown. 7 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Recruiting 3, Not yet recruiting 2, Completed 1, Unknown 1
Phase 11Unknown 1

Follow Intermittent Fasting: new trials by email Literature Review of Intermittent Fasting trials Research Report on Intermittent Fasting

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Targeting HealthY Eating to Maintain Energy While Living With Cancer
Nutrition counseling, Time-restricted eating - Fatigue in Cancer Survivors
Phase 2RecruitingUniversity of Maryland, Baltimore1322026-11-012026-11-03
16-Hour Fasting Plus Serplulimab and CAPEOX as Neoadjuvant Therapy in pMMR/MSS Advanced Mid-to-Low Rectal Cancer
16-Hour Fasting, Serplulimab + chemotherapy - pMMR/MSS, Locally Advanced Rectal Carcinoma
Phase 2Not yet recruitingZhejiang University512026-10-012026-09-08
Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health
Time-restricted eating (TRE) + Standard of Care, Standard of Care - Metabolic Syndrome, Pre-diabetes
Phase 2RecruitingUniversity of California, San Diego1402025-10-232026-02-02
Time Restricted Eating in Haematological Malignancies
Time-Restricted Eating - Cancer, Chronic Lymphocytic Leukemia
Phase 2Not yet recruitingBritish Columbia Cancer Agency752025-06-012025-06-13
Pivotal BE Study of TAH3311 ODF vs ELIQUIS® Tablet Under Fasted Condition in Healthy Volunteers
5 mg Apixaban Oral Dissolving Film (fasting), 5 mg Apixaban Oral Dissolving Film (fed), 5 mg Apixaban Oral Tablet (US RS/RLD) - Random Allocation, Intermittent Fasting
Phase 2CompletedTAHO Pharmaceuticals Ltd.602024-11-162025-04-11
Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
Time-restricted eating, Nutrition counseling - Neoplasms, Blood Cancer
Phase 2RecruitingUniversity of Maryland, Baltimore962024-11-042026-06-05
The Effect of Time-restricted Feeding on Physiological Function in Middle-aged and Older Adults
Time Restricted Feeding - Aging
Phase 1 / Phase 2UnknownUniversity of Colorado, Boulder122016-04-012019-06-14

Narrower conditions

Neoplasms (2)  ·  Fasting (1)  ·  Fatigue (1)  ·  Feeding Behavior (1)  ·  Frailty (1)  ·  Glucose Intolerance (1)  ·  Hematologic Neoplasms (1)  ·  Inflammation (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Metabolic Syndrome (1)  ·  Rectal Neoplasms (1)

Broader conditions

Behavior (7)  ·  Fasting (6)  ·  Feeding Behavior (6)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Neoplasms by Site (2)  ·  Pathologic Processes (2)  ·  Behavior, Animal (1)  ·  Chronic Disease (1)  ·  Colorectal Neoplasms (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Disease Attributes (1)  ·  Gastrointestinal Diseases (1)

Interventions

Drug Therapy (1)  ·  Standard of Care (1)  ·  Trehalase (1)  ·  apixaban (1)

Sponsors

University of Maryland, Baltimore (2)  ·  British Columbia Cancer Agency (1)  ·  TAHO Pharmaceuticals Ltd. (1)  ·  University of California, San Diego (1)  ·  University of Colorado, Boulder (1)  ·  Zhejiang University (1)

Countries

United States (5)  ·  Canada (1)

Top investigators

Christopher R Martens, Ph.D. (1)  ·  Eleah Stringer, MSc, RD, CSO (1)  ·  Pam Taub, MD (1)  ·  Tiffany A Bradley, MD (1)

Results publications

PMID 33512717, PMID 41174725